• Core Scientific entered USD 600 million of committed senior secured credit facilities, including a USD 100 million revolving credit facility.
• The package also includes a USD 500 million letter of credit facility to support utility-related project obligations.
• The facilities are expected to release about USD 300 million of restricted cash, boosting liquidity and financial flexibility.
• Revolver matures in three years, priced at adjusted SOFR + 1.75% or base rate + 0.75%.
• Morgan Stanley led the financing; JPMorgan serves as administrative agent; commitments expected to be split equally among four banks.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Core Scientific Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260827973968) on August 27, 2026, and is solely responsible for the information contained therein.